United Therapeutics shares tumbled Wednesday after the No. 2 biotech company and IBD 50 stock widely missed profit calls.

The post IBD 50’s United Therapeutics Slumps From Its Record High On Mixed Quarter appeared first on Investor’s Business Daily.